World's most advanced form of radiotherapy coming to Manchester
Press Release Posted 05 April 2012
The Christie is set to bring to Manchester a new
form of advanced cancer treatment for a wide range of cancers
particularly benefitting children and young adults.
The Christie, along with its partners, has won a national tender
to develop a centre for Proton Beam Therapy (PBT), an advanced form
of radiotherapy which can target tumours far more precisely than
Success has come as a result of a collaborative approach by The
Christie with its partners Central Manchester University Hospital
NHS Trust, Salford Royal NHS Trust and Manchester Academic Health
Science Centre (MAHSC) and with support from Manchester City
Andrew Lansley made the announcement at a visit to the Christie
Hospital that up to £250 million will be invested by the Department
of Health in building Proton Beam Therapy facilities at The
Christie NHS Foundation Trust Hospital in Manchester and University
College London Hospitals NHS Foundation Trust.
Currently patients requiring PBT have to travel abroad for long
periods of time to receive this state of the art treatment as the
service is not available in the UK. These treatments will now be
delivered in Manchester as a national service combining the
expertise of cancer specialists from the three hospitals.
The Christie, known internationally for 100 years of world
firsts, provides radiotherapy through one of the largest
radiotherapy departments in the world, delivering 100,000
radiotherapy treatments per year. The specialist cancer
centre treats 40,000 cancer patients a year and as well as its main
site, has two radiotherapy centres in Greater Manchester.
Dr Nick Slevin, consultant at The Christie said: "For a specific
range of cancers, the advantages of proton beam therapy over
conventional radiotherapy are now unquestionable. Proton beam
therapy can very precisely target the cancer saving lives with
Caroline Shaw, Chief Executive of The Christie said: "Providing
proton beam therapy for UK patients is a naturaldevelopment for us
as true cancer specialists. This will allow us to build on
our world-class expertise and complement our existing extensive
cancer services. Patient care is our absolute priority. We
have worked closely with our Manchester based partners on this
bid. Their support, expertise and collaboration contributed
to this breakthroughand both Greater Manchester and communities
across the UK will certainly see the significant benefit in years
A joint proposal to provide a national PBT service with
University College London Hospitals NHS Foundation Trust (UCLH),
will offer the first PBT service in the UK, allowing unparalleled
access for patients and their families from all over the UK. Around
[1,500 patients] will be treated with Proton Beam Therapy, every
The new service will bring together some of the world's leading
specialists in complex cancers. Together, UCLH and The
Christie will see more children and teenagers with cancer than
almost any other centre in the world, and more adults with brain
cancers than any other centre in the UK.
Dr Ed Smith, a consultant paediatric oncologist at The Christie,
"Children and young people in the UK will benefit from local
access to this advanced form of treatment, with better outcomes and
less chance of long term side effects. This exciting
development for Manchester will build on an already large and
comprehensive paediatric oncology service."
Proton Beam Therapy is beneficial for many child cancer cases,
but is also used to treat brain cancers, head and neck cancers and
David Dalton, Chief Executive of Salford Royal NHS Foundation
"Patients will now not have to travel oversees for this
treatment, at a time when they are trying to cope with their
condition, this is simply great news and we are delighted that we
are playing a major part in this. By working together with partners
in this way, it will ensure that we all continue to provide the
best possible clinical outcome and high quality care to those
patients who are in need of this treatment. This partnership has
strengthened our regions neuroscience, cancer and paediatric
expertise and services."
Mike Deegan, Chief Executive of Central Manchester University
Hospitals NHS Foundation Trust adds:
"This is fantastic news for everyone, staff, patients and most
importantly the children and their families who will now be able to
access this state-of-the-art therapy without having to travel
abroad. We are proud to be part of the team bringing this new
technology to the UK and are looking forward to working with our
partners to develop a world class PBT service that builds on
Manchester's unparalleled facilities and expertise in the treatment
Mike Emmerich, Chief Executive New Economy Manchester said:
"This is fantastic news for Manchester and is a further boost to
the City's ambitions to establish Manchester as a world class
centre for science and innovation."
This is another major step forward for Manchester, after itwas
officially ranked the best centre in the country for cancer
research in the last national Research Assessment Exercise.
This Proton Beam Therapy (PBT) service will start treating
patients towards the end of 2017.
End of the article, where next?
Back to Latest News
Back to Top
Meet the news team